EUVIMEDEUVIMED entdecken
Crossref

Additive and Dose‐Dependent Effects of Coenzyme Q10 Combined With Myoinositol on Insulin Resistance and Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Retrospective Controlled Study

Burcu Dincgez iD, Gulten Ozgen iD, Nergis Kender Erturk iD, Hazel Cagın Kuzey iD, Esra Kartal Golcuk iD

Journal of Obstetrics and Gynaecology Research · 2026

DOI: 10.1111/jog.70502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Burcu Dincgez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Bursa Yuksek Ihtisas Research and Training Hospital, Bursa, Turkey. Hauptthemen laut MEDLINE: Inositol, Polycystic Ovary Syndrome, Ubiquinone, Insulin Resistance. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Polycystic ovary syndrome (PCOS) is characterized by insulin resistance, hyperandrogenism, and reproductive dysfunction. Myoinositol and coenzyme Q10 (CoQ10) have complementary metabolic and hormonal effects; however, the additive and dose‐dependent effects of CoQ10 remain unclear. This study evaluated these effects in women with PCOS.

Methods

In this retrospective study, 200 women with PCOS were assigned to four groups: myoinositol plus CoQ10 100 mg ( n = 55), myoinositol plus CoQ10 200 mg ( n = 55), myoinositol alone ( n = 45), and untreated controls ( n = 45). Fasting insulin, HOMA‐IR, total testosterone, and menstrual cycle regularity were assessed at baseline and 6 months. Between‐group differences were evaluated using multivariable regression analyses and sensitivity analyses.

Results

All treatment groups showed improvements in metabolic and hormonal parameters, with the greatest effects observed in the combination therapy groups. Myoinositol alone was associated with significant reductions in HOMA‐IR ( β = −0.219; p < 0.001) and total testosterone ( β = −3.145; p < 0.001) compared with untreated controls. The addition of CoQ10 resulted in dose‐dependent improvements, with 100 and 200 mg doses demonstrating progressively greater reductions in HOMA‐IR ( β = −0.308 and −0.571, respectively) and total testosterone ( β = −2.847 and −5.325, respectively) (all p < 0.001). Multivariable regression analyses confirmed that both CoQ10 doses remained significantly superior to myoinositol monotherapy. Menstrual cycle regularity improved most in the MI + CoQ10 200 mg group (36.4%).

Conclusion

Adjunctive CoQ10 supplementation with myoinositol provides significant and dose‐dependent improvements in insulin resistance and hyperandrogenism in PCOS. The magnitude of reduction observed with 200 mg CoQ10 suggests potential clinical relevance, particularly in metabolically compromised patients. Prospective randomized studies are warranted to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InositolPolycystic Ovary SyndromeUbiquinoneInsulin ResistanceHyperandrogenismVitaminsHumansFemaleRetrospective StudiesAdultDrug Therapy, CombinationDose-Response Relationship, DrugYoung Adult

Stichwörter der Autor:innen

coenzyme Q10combination therapyhyperandrogenismmyoinositolpolycystic ovary syndrome

Substanzen

InositolUbiquinonecoenzyme Q10Vitamins

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Bursa Yuksek Ihtisas Research and Training Hospital, Bursa, Turkey.
  • Faculty of Medicine, Biruni University, Istanbul, Turkiye.
  • Department of Obstetrics and Gynecology, Memorial Sisli Hospital, Istanbul, Turkey.

ORCID-Profile: Burcu Dincgez, Gulten Ozgen, Nergis Kender Erturk, Hazel Cagın Kuzey, Esra Kartal Golcuk

Zitieren

APA

Dincgez, B., Ozgen, G., Erturk, N. K., Kuzey, H. C., & Golcuk, E. K. (2026). Additive and Dose‐Dependent Effects of Coenzyme Q10 Combined With Myoinositol on Insulin Resistance and Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Retrospective Controlled Study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70502

Vancouver

Dincgez B, Ozgen G, Erturk NK, Kuzey HC, Golcuk EK. Additive and Dose‐Dependent Effects of Coenzyme Q10 Combined With Myoinositol on Insulin Resistance and Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Retrospective Controlled Study. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70502

BibTeX
@article{Dincgez2026,
  author = {Dincgez, Burcu and Ozgen, Gulten and Erturk, Nergis Kender and Kuzey, Hazel Cagın and Golcuk, Esra Kartal},
  title = {Additive and Dose‐Dependent Effects of Coenzyme Q10 Combined With Myoinositol on Insulin Resistance and Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Retrospective Controlled Study},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  doi = {10.1111/jog.70502}
}
Kostenlos starten →